Perspectives on rheumatoid arthritis for the orthopedic surgeon: overview of non-tumor necrosis factor biologic drugs and perioperative management.

American journal of orthopedics (Belle Mead, N.J.)

Volumn 40, Issue 12, 2011, Pages

  Keith, Michael P ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; ANTIRHEUMATIC AGENT; METHOTREXATE; MONOCLONAL ANTIBODY; RITUXIMAB; TOCILIZUMAB;

ARTICLE; DRUG COMBINATION; HEALTH CARE QUALITY; HUMAN; ORTHOPEDICS; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOCONJUGATES; METHOTREXATE; ORTHOPEDICS; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; STANDARD OF CARE;

EID: 84861132017     PISSN: None     EISSN: 19343418     Source Type: Journal    
DOI: None     Document Type: Article

References (0)